Related Experiment Videos
Langerhans' cell histiocytosis
M C Velez-Yanguas1, R P Warrier
1Department of Pediatric Hematology/Oncology, Louisiana State University Medical Center and Children's Hospital, New Orleans 70118, USA.
The Orthopedic Clinics of North America
|July 1, 1996
Summary
Langerhans
Area of Science:
- Histiocytosis and related syndromes
- Pediatric hematology-oncology
- Cellular biology
Background:
- Langerhans' Cell Histiocytosis (LCH) encompasses several conditions, including eosinophilic granuloma, Hand-Schuller-Christian disease, and Letterer-Siwe disease.
- Historically, these were grouped under the term Histiocytosis X.
- Understanding LCH requires knowledge of its diverse clinical presentations and underlying biology.
Purpose of the Study:
- To provide a comprehensive review of Langerhans' Cell Histiocytosis.
- To discuss the biological basis, clinical features, and therapeutic strategies for LCH.
- To differentiate between localized and disseminated forms of the disease.
Main Methods:
- Literature review of Langerhans' Cell Histiocytosis and related syndromes.
- Synthesis of information on disease biology, clinical manifestations, and treatment options.
- Categorization of LCH into localized and disseminated forms for discussion.
Main Results:
- Langerhans' Cell Histiocytosis presents as a spectrum of diseases with varying severity.
- Clinical manifestations range from localized bone lesions to multisystemic involvement.
- Treatment strategies are tailored to the extent and severity of the disease.
Conclusions:
- Langerhans' Cell Histiocytosis is a complex disorder with diverse presentations.
- Effective management requires a thorough understanding of its biology and clinical spectrum.
- Treatment approaches vary based on whether the disease is localized or disseminated.